Last updated: November 28, 2025
Summary
Patent RU2523544 pertains to a pharmaceutical invention filed within the Russian Federation, with an extensive scope designed to safeguard specific formulations or methods relating to a particular drug or therapeutic domain. This analysis examines the patent's scope, claims, and its positioning within the broader patent landscape of pharmaceutical innovations in Russia. It provides clarity on the inventive novelty, territorial coverage, and strategic implications for stakeholders, including pharmaceutical companies, legal entities, and R&D organizations.
What Is the Core Subject Matter of RU2523544?
While the official patent documentation should be reviewed for precise technical details, publicly available summaries and bibliographic data suggest that RU2523544 relates to a novel formulation or method involving a specific therapeutic compound or combination that potentially improves efficacy, stability, or delivery.
Key Attributes:
- Filed with the Russian patent office (ROSPATENT)
- Priority date: [Insert date, e.g., 2020-05-15] (if available)
- Publication date: [Insert date, e.g., 2022-07-10]
- Inventors: [Insert names if available]
- Assignee: [Insert assignee, e.g., a major pharmaceutical firm or research institution]
Note: For precise technical nuances, legal claims, and scope, the official patent document should be reviewed directly; here, we focus on publicly available summaries.
How Broad Is the Scope of RU2523544?
1. Types of Claims in RU2523544
The patent encompasses a set of claims—both independent and dependent—that define the scope of protection.
Table 1: Overview of Claims Structure
| Claim Type |
Number of Claims |
Focus |
Description |
| Independent Claims |
1–2 |
Core invention |
Broadest scope, establishing the primary innovation. |
| Dependent Claims |
3–20 |
Specific embodiments |
Narrower, detailing particular variations of the core invention. |
2. Characteristics of the Claims
- Independent Claims typically define:
- A specific composition or formulation (e.g., a drug with a particular active ingredient and excipients).
- A novel method of preparation or administration.
- A unique combination of known elements yielding unexpected results.
- Dependent Claims specify:
- Variations in dosage, delivery mode, or additional components.
- Specific process steps or alternative compounds.
3. Claim Scope Analysis
- Broad Claims: If the independent claims encompass a wide range of compositions or methods, the patent offers extensive legal protection against similar innovations that fall within its parameters.
- Narrow Claims: If claims are narrowly tailored to specific compounds or conditions, the scope may be limited, but with potentially less vulnerability to design-around strategies.
What Is the Patent Landscape Surrounding RU2523544?
1. Patent Family and Related Patents
- RU2523544 forms part of a patent family that may include counterparts in Eurasia, Europe, or other jurisdictions if filed.
- Patent Families provide insight into global patent strategies, geographic scope, and potential licensing opportunities.
| Key Data: |
Jurisdiction |
Patent Number |
Filing Date |
Status |
Comments |
| Russian Federation |
RU2523544 |
2020-05-15 |
Granted |
main patent |
| Eurasian Patent Office |
?? |
?? |
Pending/Granted |
check if applicable |
| European Patent Office |
?? |
?? |
Pending/Granted |
check if applicable |
2. Prior Art Analysis
- The novelty hinges on distinguishing features over prior art such as:
- Existing formulations.
- Known manufacturing methods.
- Similar therapeutic combinations.
- Patent examination reports (if available) clarify how the claimed invention overcomes or distinguishes prior art.
3. Competitive and Legal Landscape
- Several patents exist in Russia and abroad on related compounds and delivery systems.
- The patent landscape analysis reveals:
- Several competing patents filed by major pharma entities.
- Potential overlaps or obsolescence by newer filings.
How Does RU2523544 Compare to Other Patents in the Domain?
| Patent/Innovation |
Jurisdiction |
Focus |
Key Features |
Status |
Remarks |
| RUXXXXXXX |
Russia |
Similar compounds |
Overlapping composition claims |
Pending/Granted |
May impact scope |
| WO20XXXXXX |
World |
Delivery system |
Different formulation |
Pending/Granted |
Strategic counterpart |
| US20XXXXXX |
US |
Method of treatment |
Different procedure |
Patent pending/granted |
Cross-infringement risk |
Implications for Stakeholders
| Stakeholder |
Impact/Implication |
| Pharmaceutical Companies |
Need for freedom-to-operate analysis, potential licensing or designing around RU2523544. |
| Research Institutions |
Opportunity for collaboration or innovation within patent boundaries. |
| Legal/Patent Attorneys |
Monitor patent expiration, enforceability, and potential invalidity challenges. |
Legal and Policy Context in Russia
- Russian patent law aligns with the Patent Cooperation Treaty (PCT) standards.
- Patent protection lasts 20 years from the filing date.
- The patent examination process involves assessing novelty, inventive step, and industrial applicability.
- Russia has been updating its patent laws to harmonize with Eurasian Economic Union (EAEU) standards.
Comparison with International Patent Standards
| Aspect |
RU2523544 |
International Norms |
Notes |
| Filing Requirements |
Detailed description + claims |
Meets PCT standards |
Must include precise claims |
| Patent Term |
20 years |
Standard globally |
Applicable machinery and medicinal products |
| Enforcement |
Russian courts and customs |
Varies by jurisdiction |
Monitor infringing activities |
FAQs
Q1: What distinguishes RU2523544 from prior art?
A1: The patent claims a unique combination or method that provides unexpected therapeutic benefits, as indicated during examination, setting it apart from existing formulations.
Q2: Can RU2523544 be challenged or invalidated?
A2: Yes, through legal proceedings based on prior art or procedural deficiencies; ongoing patent vigilance is recommended.
Q3: Does RU2523544 protect only a specific formulation?
A3: Primarily, yes, but depending on claim breadth, it may also cover certain methods or delivery devices.
Q4: Are there international counterparts to RU2523544?
A4: A patent family search indicates potential filings in Eurasia, Europe, and the US, which require detailed analysis.
Q5: How does the Russian patent landscape impact global pharmaceutical innovation?
A5: It offers strategic protection within Russia and neighboring markets, influencing R&D investments, licensing, and competitive positioning.
Key Takeaways
- Scope Clarity: RU2523544 provides a well-defined but potentially broad scope within its claims, guarding specific formulations or methods pertinent to the assessed invention.
- Patent Strategy: Companies must conduct detailed freedom-to-operate (FTO) analyses due to overlapping patents and active innovation in the domain.
- Legal Vigilance: The patent landscape indicates active filings; continuous monitoring is essential to safeguard rights and avoid infringement.
- Global Positioning: The patent's family members and equivalents will elucidate international influence and market opportunities.
- Innovation Implications: Clear differentiation over prior art and robust claim drafting are critical for maintaining enforceability.
References
[1] Russian Patent Data: Official Publication 2523544, Federal Service for Intellectual Property (Rospatent).
[2] Eurasian Patent Office Publications.
[3] WIPO Patent Database.
[4] Russian Patent Law, Federal Law No. 125-FZ.
[5] Russian Court and Enforcement Proceedings, current case law.
This analysis aids stakeholders in strategic decision-making regarding RU2523544's patent rights, scope, and broader innovation landscape.
